← Back to Search

Behavioral Intervention

Intervention for Heart Failure

N/A

Recruiting

Led By Anup Agarwal, MD

Research Sponsored by Medstar Health Baltimore

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age >18 years

Patients diagnosed with Heart Failure reduced Ejection Fraction (EF≤40%)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

"This trial aims to see if educating patients can help them better follow the recommended medical treatment for heart failure with reduced ejection fraction. Participants will receive education about the benefits of this treatment at different time points

Who is the study for?

This trial is for patients with heart failure where the heart's pumping power is reduced. They should be recently discharged from the hospital and willing to learn about their treatment guidelines at set intervals after discharge.Check my eligibility

What is being tested?

The study tests if teaching patients about their heart failure treatments can help them stick to these plans better. Participants will get special education sessions on this topic 1, 3, and 5 months after leaving the hospital.See study design

What are the potential side effects?

Since this trial focuses on education rather than medication or procedures, there are no direct side effects related to drugs or surgical interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am older than 18 years.

Select...

My heart's pumping ability is significantly reduced.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in GDMT score

Secondary outcome measures

Heart Failure hospitalization

Number of GDMT classes of medications in use

cardiovascular death/Left Ventricular Assist Device implantation/Cardiac Transplant

Trial Design

2Treatment groups

Active Control

Group I: InterventionActive Control1 Intervention

Intervention arm will receive initial face to face education during hospital admission and also an educational flier about GDMT. They will get 3 more sessions of education over phone at 1, 3 and 5 months after discharge, each session includes an overview of benefits and side effects of GDMT, inquiries about reasons of not using optimal doses of GDMT medications, and encouraging adherence to visits with providers.

Group II: ControlActive Control1 Intervention

Control arm will receive initial face to face education during hospital admission and also an educational flier about GDMT.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Medstar Health BaltimoreLead Sponsor

Anup Agarwal, MDPrincipal InvestigatorMedStar Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants still being accepted for enrollment in this research study?

"According to data available on clinicaltrials.gov, this research initiative is currently in the process of enrolling participants. The trial was initially listed on February 1st, 2024 and its latest update was recorded on February 15th, 2024."

Answered by AI

What is the current number of participants being enrolled in this clinical research study?

"Affirmative. Details available on clinicaltrials.gov indicate that this research endeavor is actively pursuing candidates for participation. The study was initially made public on February 1st, 2024, and received its latest update on February 15th of the same year. This trial aims to recruit a total of 500 individuals distributed across four distinct sites."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Intensive Education Versus Usual Education of Patients for Improving Guideline Directed Medical Therapy (GDMT) Prescription in Heart Failure With Reduced Ejection Fraction

2024. "Intensive Education Versus Usual Education of Patients for Improving Guideline Directed Medical Therapy (GDMT) Prescription in Heart Failure With Reduced Ejection Fraction". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06273085.

All > Paid Studies Baltimore